Valeant says California judge gives preliminary approval to Allergan settlement


LAVAL, Que. - Valeant Pharmaceuticals International Inc. says a U.S. District Court judge gave his preliminary approval Tuesday to a US$290-million settlement of lawsuits stemming from the unsuccessful attempted hostile takeover in 2014 of Botox maker Allergan Inc. As part of the deal agreed to in December, Quebec-based Valeant will pay US$96.25 million, with co-defendant Pershing Square Capital Management, L.P. paying the rest.



from Biotech News